Navigation Links
Olk Design Sponge Implants - 5.0 x 2.5 x 80 mm

ProductsOlk Design Sponge Implants - 5.0 x 2.5 x 80 mm
Company Bausch & Lomb Storz
Item Olk Design Sponge Implants - 5.0 x 2.5 x 80 mm
Features 
Description Size: 5.0 x 2.5 x 80 mm. Half oval. The original Scleral Sponge II line designed by Harvey A. Lincoff, M.D. has been modified by Dr. Joseph Olk with this half oval design. The material is a closed cell sponge which is non-toxic and non-antigenic. Implants are soft with rounded edges to minimize scleral intrusion. These implants are packaged sterile and sold five implants per box.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000

Related medicine products :

1. Olk Design Sponge Implants - 7.5 x 2.75 x 80 mm
2. Sun Design Chairs
3. Contour Design Eyelid Implants
4. ThinProfile Design Eyelid Implants
5. PINNACLE Introducer Sheath Designed for Vascular Access
6. CHECK-FLO Performer Introducers BALKIN Up & Over Contralateral Design with Radiopaque Band
7. FLEXOR Introducers BALKIN Up & Over Contralateral Design with Radiopaque Band
8. CHECK-FLO Performer Introducers MULLINS Design with Radiopaque Band
9. CHECK-FLO Performer Introducers High-Volume Infusion Design
10. MarShield Comfort Design
11. Weil Type Swanson Design Hammertoe Implant
VascoStim B 2/5F is a bipolar temporary pacing lead with a balloon. It can be placed easily by the resistance of the inflated balloon in the blood flow.
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs.
The Aescula LV left-heart lead is a stylet-driven, silicone insulated lead with a titanium nitride (TiN) coated platinum-iridium electrode.
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl
Medicine Products:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...ffects a woman both mentally and physically.// Fr...e University’s Institute for Social and Behavioura...of getting a divorce produced no immediate effects...ve effects on mental health. “Ten years later, tho...
... the idea of listing the calorie content of the fo...sh out consistent portions. Fast-food brands have ... They fear that this would make an apology of the...e with time in reaching food to the table. Comm...
...the anger of children with behavioural problems, s... problems and emotional difficulties, including au...aton Hall Special School in Norwich and found that...daily doses of the fatty acids, reported the onlin...
...the virtues of the NHS, staff who run the service ...olicies of the NHS. // The Department of Health re...d staff numbers but NHS staff including doctors, n... has taken to the streets of Westminster to protes...
Other Medicine News:Health News:Wide Differences between NHS staff and ministers 2
(Date:9/5/2008)...swire/ -- The Florida,Technology, Research and Sch...niversity researcher Dr. Herbert Weissbach, distin...olecular Biology and,Biotechnology in the Charles ...LC (CHS), $184,294 as part of the State University...am (SURECAG). SURECAG was,established by the Flori...
(Date:9/5/2008)...swire-FirstCall/ -- SARcode,Corporation, a private...s,to treat inflammatory diseases, and Sunesis Phar...ARcode,s initiation of a Phase 1 clinical trial of...ll mediated ophthalmic,diseases. Sunesis and SARco...ode with an exclusive license to Sunesis, LFA-1 te...
(Date:9/4/2008)...-- Cytopia Limited (ASX:,CYT) today announced that...udy of CYT997, the company,s novel vascular-disrup...ive form of brain cancer known as glioblastoma,mul...st Phase II efficacy study in highly,vascular, sol...d in its,suite of Phase II studies designed to inv...
(Date:9/4/2008)... testing for the diagnostic ...wswire/ -- The U.S. Food & Drug,Administration (FD...est,the first assay for quantitating Hepatitis B ...,s real-time PCR technology to quantify the amount...ctors may use viral load,testing results to establ...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Michael D Taylor Ph D Joins Cequent Pharmaceuticals Board of Directors 5095 1Michael D Taylor Ph D Joins Cequent Pharmaceuticals Board of Directors 5095 2ESA contributes to ocean carbon cycle research 18388 1ESA contributes to ocean carbon cycle research 18388 2InfoLogix Acquires Delta Health Systems 3B Adds Strategic Cost Management Consulting Services at the Executive Level 18384 1InfoLogix Acquires Delta Health Systems 3B Adds Strategic Cost Management Consulting Services at the Executive Level 18384 2InfoLogix Acquires Delta Health Systems 3B Adds Strategic Cost Management Consulting Services at the Executive Level 18384 3InfoLogix Acquires Delta Health Systems 3B Adds Strategic Cost Management Consulting Services at the Executive Level 18384 4National Marrow Donor Program 28R 29 Kicks off National Awareness Campaign 18379 1National Marrow Donor Program 28R 29 Kicks off National Awareness Campaign 18379 2National Marrow Donor Program 28R 29 Kicks off National Awareness Campaign 18379 3